Osimertinib Active Not Recruiting Phase 1 Trials for Advanced Non Small Cell Lung Cancer / Advanced (Inoperable) Non Small Cell Lung Cancer Other

Active Not RecruitingOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT02163733Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer
NCT02157883Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)